Last reviewed · How we verify
NCT03892824: CAPTURE2
Carotid Artery Implant for Preventing Stroke in Atrial Fibrillation Patients Taking Oral Anticoagulants
NA trial testing Vine™ Embolic Protection System in Atrial Fibrillation in 100 participants. Participants enrolled and being followed up; not accepting new ones.
24 October 2024
Quick facts
| Lead sponsor | Javelin Medical |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 100 |
| Start date | 15 April 2019 |
| Primary completion | 24 October 2024 |
| Estimated completion | 24 October 2027 |
| Sites | 17 locations across Czechia, Poland, Belgium, Israel, Hungary, Greece, Germany, Spain |
Drugs / interventions tested
- Vine™ Embolic Protection System
Conditions studied
- Atrial Fibrillation — all drugs for Atrial Fibrillation →
- Stroke — all drugs for Stroke →
Sponsor
Javelin Medical
Who can join
50 and older, any sex, with Atrial Fibrillation or Stroke. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will assess the safety and performance of the Vine™ Embolic Protection System (embolic filtering device) in atrial fibrillation (AF) patients on top of oral anticoagulants (OAC), and remain at high risk for stroke recurrence. All patients will receive bilateral implants in the common carotid arteries
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Permanent Bilateral Carotid Filters for Stroke Prevention in Atrial Fibrillation.
De Potter T, Yodfat O, Shinar G, Neta A, et al · · 2020 · cited 6× · PMID 32910288 · DOI 10.1007/s11886-020-01388-w
Verify or expand the search:
- PubMed search for NCT03892824
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Atrial Fibrillation
Currently open trials in the same condition.
- NCT07429214 — A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAF · NA · recruiting
- NCT07271238 — Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures · NA · recruiting
- NCT07388108 — Atrial Dyssynchrony to Predict Arrhythmias in the Postoperative Setting of Cardiovascular Surgery. · recruiting
- NCT07428967 — AV Node Ablation and CONDUCTion System Pacing for Atrial Fibrillation With Preserved Left Ventricular Function · NA · recruiting
- NCT06650995 — AlEX-DHF: Ablation and Exercise in Diastolic Heart Failure · NA · recruiting
Other Javelin Medical trials
Trials by the same sponsor.
- NCT05723926 — Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated · NA · recruiting
- NCT03571789 — Carotid Artery Implant for Trapping Upstream Emboli for Preventing Stroke in Atrial Fibrillation Patients · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03892824 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Javelin Medical
- Last refreshed: 20 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03892824.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing